Division of Pediatric Neurology, Department of Pediatrics I, Medical University of Innsbruck, Innsbruck, Austria.
Division of Pediatric Pulmonology, Allergology and Endocrinology, Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.
Eur J Paediatr Neurol. 2024 May;50:86-95. doi: 10.1016/j.ejpn.2024.04.011. Epub 2024 Apr 24.
Patients with myelin oligodendrocyte glycoprotein antibody-associated disorders (MOGAD) clinically present e.g. with acute disseminated encephalomyelitis (ADEM), optic neuritis (ON), transverse myelitis (TM) or aquaporin-4-IgG (AQP4-IgG) negative neuromyelitis optica spectrum disorders (NMOSD)-like phenotypes. We aimed to analyze and compare blood parameters in children with MOGAD, AQP4-IgG-positive NMOSD (hence NMOSD), multiple sclerosis (MS) and healthy controls (HC).
We evaluated differences in complete blood counts (CBC), neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR) and C-reactive protein (CRP) between these four groups and within the groups between clinical attack, acute treatment and remission.
Our cohort consisted of 174 children and adolescents with a total of 550 timepoints: 66 patients had MOGAD (202 timepoints), 11 NMOSD (76 timepoints), 58 MS (219 timepoints) and 39 were HC (53 timepoints). At clinical attack, leukocyte counts were elevated in MOGAD compared to remission (p < 0.001) and compared to all other groups (p < 0.001). NLR was high in MOGAD and NMOSD, and PLR was high in NMOSD, however, after correction for multiple testing these findings did not remain significant. While glucocorticoids caused an increase of leukocyte counts and NLR in NMOSD and MS, these values remained stable during acute treatment in MOGAD. In remission, NLR normalized in MOGAD, while it stayed high in NMOSD. PLR increased in NMOSD and was significantly higher compared to all other groups.
Some blood parameters, mainly leukocyte and differential counts, might help clinicians to evaluate disease activity, differentiate relapses from pseudo-relapses and even distinguish between different disease entities.
髓鞘少突胶质细胞糖蛋白抗体相关性疾病(MOGAD)患者临床表现为急性播散性脑脊髓炎(ADEM)、视神经炎(ON)、横贯性脊髓炎(TM)或水通道蛋白 4 抗体(AQP4-IgG)阴性视神经脊髓炎谱系疾病(NMOSD)样表型。本研究旨在分析和比较 MOGAD、AQP4-IgG 阳性 NMOSD(NMOSD)、多发性硬化症(MS)和健康对照组(HC)患儿的血液参数。
我们评估了这四组患者的全血细胞计数(CBC)、中性粒细胞与淋巴细胞比值(NLR)、血小板与淋巴细胞比值(PLR)、单核细胞与淋巴细胞比值(MLR)和 C 反应蛋白(CRP)之间的差异,并在组内比较了临床发作、急性治疗和缓解期之间的差异。
本研究共纳入 174 例儿童和青少年,共计 550 个时间点:66 例 MOGAD(202 个时间点)、11 例 NMOSD(76 个时间点)、58 例 MS(219 个时间点)和 39 例 HC(53 个时间点)。在临床发作时,MOGAD 患者的白细胞计数高于缓解期(p<0.001)和其他所有组(p<0.001)。MOGAD 和 NMOSD 患者的 NLR 较高,NMOSD 患者的 PLR 较高,但校正多重检验后,这些发现不再具有统计学意义。在 NMOSD 和 MS 中,糖皮质激素治疗会导致白细胞计数和 NLR 升高,但在 MOGAD 中,这些值在急性治疗期间保持稳定。在缓解期,MOGAD 患者的 NLR 恢复正常,而 NMOSD 患者的 NLR 仍较高。NMOSD 患者的 PLR 升高,明显高于其他所有组。
一些血液参数,主要是白细胞和分类计数,可能有助于临床医生评估疾病活动度,区分复发与假性复发,甚至区分不同的疾病实体。